Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Colonic Diseases

2-amino-5-phosphonovalerate has been researched along with Colonic Diseases in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, X1
Gao, J1
Yan, J1
Fan, J1
Owyang, C1
Li, Y1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Colonic Diseases

ArticleYear
Role for NMDA receptors in visceral nociceptive transmission in the anterior cingulate cortex of viscerally hypersensitive rats.
    American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 294, Issue:4

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Anaphylaxis; Animals; Cerebral Co

2008